Mr. Nally is leaving Merck to take a leadership role with another company, according to the news release. He joined Merck in 2003.
Frank Clyburn, Merck’s chief commercial officer, was named as the president of the drugmaker’s human health division. He will now lead all marketing and commercial operations for Merck’s human health division globally.
Mr. Clyburn, who joined Merck in 2008, will report to Merck CEO Ken Frazier until April 1. Once Robert Davis, Merck’s current executive vice president of global services and CFO, takes over as president April 1, Mr. Clyburn will report to him. Mr. Davis will become CEO July 1.
More articles on pharmacy:
AbbVie reportedly in talks to sell $5B women’s health portfolio
NYC pharmacist charged in $4M kickback, fraud scheme
94% of older Americans prescribed a drug that increases their risk of falling, study shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
